Help with addiction starts with one call.

877-922-8999
Person Person Person

Thousands of people helped nationwide.

BMC MAT E/Catalyst - Boston

Open Now
Contact Information
725 Albany Street, Boston, MA, Massachusetts 02118
0.000
Detailed Information

BMC MAT E/Catalyst – Boston

Located in the heart of Boston, Massachusetts, BMC MAT E/Catalyst provides essential outpatient treatment services designed to help individuals struggling with substance use disorders find lasting recovery. This program is dedicated to offering specialized care that addresses the complex nature of addiction, ensuring that patients receive comprehensive support tailored to their unique needs.

Specialized Treatment Focus

BMC MAT E/Catalyst is particularly focused on treating opioid use disorders, which includes dependencies on substances such as heroin, fentanyl, and prescription painkillers. The facility employs Medication-Assisted Treatment (MAT) as a cornerstone of its clinical approach. MAT combines FDA-approved medications with counseling and behavioral therapies, recognized as the most effective path for many individuals seeking to overcome opioid addiction.

Outpatient Services for Adults

The facility exclusively offers outpatient treatment, making it an ideal option for adults and young adults who require flexibility to maintain their daily responsibilities—such as work, family commitments, or education—while receiving treatment. The structure of outpatient care allows individuals to live at home and attend scheduled sessions, fostering recovery within their existing community support system.

Treatment programs are personalized and may incorporate a variety of evidence-based practices aimed at promoting long-term sobriety and stability. Patients work closely with clinicians to develop coping strategies, address underlying mental health issues that may co-occur with addiction, and build a solid foundation for a healthy future. Medications commonly utilized in treatment include buprenorphine and naltrexone, which assist in managing cravings and preventing relapse.

Contact and Location

BMC MAT E/Catalyst is situated at 725 Albany Street, Boston, MA 02118. Prospective patients or loved ones seeking more information are encouraged to call to discuss admission and program details.

Frequently Asked Questions (FAQs)

  • What is the primary age group treated at BMC MAT E/Catalyst? The facility offers treatment services specifically for adults and young adults seeking help for substance use disorders.
  • Does this facility offer residential or inpatient treatment? No, BMC MAT E/Catalyst specializes in outpatient treatment, allowing patients to live at home while attending scheduled treatment sessions.
  • What types of addiction are treated here? While the program treats various substance use disorders, it has a specialized focus on opioid addictions, utilizing Medication-Assisted Treatment (MAT) with medications like buprenorphine and naltrexone.

For more detailed information or to verify insurance coverage, please contact the facility directly at (617) 414-6655.

Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Type of Care
Substance use treatment
Service Setting
Outpatient, Outpatient detoxification, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Hospitals
General Hospital (including VA hospital)
Opioid Medications used in Treatment
Buprenorphine used in Treatment, Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Buprenorphine with naloxone
Buprenorphine without naloxone
Buprenorphine (extended-release, injectable)
Naltrexone (oral)
Naltrexone (extended-release, injectable)
Medications for HIV treatment
Medications for Hepatitis C treatment
Clonidine
Medications for pre-exposure to prophylaxis
Medication for mental disorders
Nicotine replacement
Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention
Cognitive behavioral therapy
Contingency management/motivational incentives
Motivational interviewing
Relapse prevention
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
Facility Operation
Private non-profit organization
License/Certification/Accreditation
State department of health
Hospital licensing authority
The Joint Commission
National Committee for Quality Assurance (NCQA)
Find Help (877) 922-8999